Skip to main content
. 2015 Nov 2;10:154. doi: 10.1186/s13012-015-0336-8

Table 3.

Trial 2: clinical effectiveness of the WATI, characteristics of active smokers registering from clinical practicesa, b

Total Control Messaging Personalized
N % N % N % N %
Patient Sex
 Female 570 63 185 62 104 63 281 64
 Male 330 37 114 38 60 37 156 36
Patient Age
 19–34 152 17 47 16 27 16 78 18
 35–55 454 50 155 52 77 47 222 51
 55–64 224 25 71 24 48 29 105 24
 65+ 70 8 26 9 12 7 32 7
Patient race
 White 769 85 253 85 144 88 372 85
 Black or African American 87 10 33 11 14 9 40 9
 Others 44 5 13 4 6 4 25 6
Patient education
 Less than high school 75 8 24 8 15 9 36 8
 High school graduate 270 30 88 30 41 25 141 33
 Some college 380 43 139 47 71 44 170 39
 College graduate or more 167 19 46 15 35 22 86 20
Readiness to quit c
 Not thinking of quitting 34 4 13 4 4 2 17 4
 Thinking of quitting 699 82 246 83 138 84 315 81
 Set a quit date 117 14 39 13 22 13 56 14
Allow smoking at home
 No 460 51 146 49 77 47 237 54
 Yes 440 49 153 51 87 53 200 46
Number of cigarettes per day
 0–10 241 27 84 28 42 26 115 26
 11–20 460 51 149 50 81 49 230 53
 >20 199 22 66 22 41 25 92 21
Visited other smoking cessation websites before
 No 782 87 264 88 142 87 376 86
 Yes 118 13 35 12 22 13 61 14
Quit attempt (1 day or more) in past 12 months
 No 424 47 148 50 71 43 205 47
 Yes 476 53 151 51 93 57 232 53

a Nine hundred ninety patients registered, of whom only 900 were current smokers (see Fig. 3). b Characteristics were not significantly different between randomized groups (control, messaging, personalized). c Denominator 850 for this variable, as 50 patients did not complete status at initial registration